ANI Pharmaceuticals, Inc. (BST:BSFA)

Germany · Delayed Price · Currency is EUR

63.00

-2.00 (-3.08%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Generics and Other		320.03M	289.31M	235.24M	-	-
Generics and Other Growth		10.62%	22.99%	-	-	-
Rare Disease and Brands		294.34M	197.50M	81.15M	-	-
Rare Disease and Brands Growth		49.03%	143.38%	-	-	-
Generics, Established Brands, and Other		-	-	-	216.14M	208.48M
Generics, Established Brands, and Other Growth		-	-	-	3.67%	0.93%
Total		614.38M	486.82M	316.39M	216.14M	208.48M
Total Growth		26.20%	53.87%	46.38%	3.67%	0.93%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States		604.99M	486.25M	312.43M	211.89M	202.88M
United States Growth		24.42%	55.64%	47.45%	4.44%	1.61%
Canada		9.39M	565.00K	3.96M	4.24M	5.59M
Canada Growth		1561.42%	-85.73%	-6.72%	-24.15%	-18.74%
Total		614.38M	486.82M	316.39M	216.14M	208.48M
Total Growth		26.20%	53.87%	46.38%	3.67%	0.93%

Source: S&P Global Market Intelligence.